Intraoral negative-pressure therapy with the iNAP Lite system demonstrated modest but significant improvement in mild-to-moderate obstructive sleep apnea–hypopnea syndrome. Mean apnea–hypopnea index decreased by approximately 26% on the first treatment night, with improved sleep continuity and good tolerability, supporting iNAP as a practical non-CPAP alternative for selected patients.
Blog Category
Intraoral Negative Pressure Therapy in Mild-to-Moderate OSAHS
By taevas on 7th Jan 2026
Experience
Innovation
Firsthand
Our innovation targets the deepest challenges in healthcare, from patient discomfort to diagnostic uncertainty. We deliver breakthrough solutions that improve compliance, provide swift, accurate diagnoses, and create pathways to healing that never existed before.
Subscribe to
Taevas Perspectives
Insights on healthcare innovations, market trends & health care advancements.